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Background: Unicompartmental knee replacement (UKR) has worse revision rates than total 5 
knee replacement, despite offering other substantial benefits. Registries suggest revision rates 6 
for cementless UKR are less than cemented. It is not known how much of this is due to the 7 
implant, or other factors like more high-volume surgeons using cementless. We aimed to 8 
determine the effect of surgeon caseload on the revision rate of matched cemented and 9 
cementless UKRs.  10 
 11 
Methods: From 40,552 Oxford UKR (30,814 cemented, 9708 cementless) recorded in the 12 
National Joint Registry,14,814 were propensity score matched (7,407 cemented, 7,407 13 
cementless). Surgeons were categorized in low (<10 cases/year), medium (10 to <30 14 
cases/year) and high volume (≥30 cases/year) groups. The effect of caseload on the relative 15 
risk of revision was assessed using cox regression. 16 
 17 
Results: The ten-year survival for unmatched cementless and cemented UKR were 93.3% 18 
(95% CI=89.8–95.7) and 89.1% (CI=88.6-89.6) respectively, with the difference being 19 
significant (hazard ratio(HR) 0.59, p<0.001). Cementless UKRs had a greater proportion of 20 
high volume surgeon users than cemented (30.4% compared to 15.1%). Following matching 21 
the ten-year survivals were 93.2% (CI=89.7-95.6) and 90.2% (CI=87.5–92.3), which were 22 
still significantly different (HR 0.76, p=0.002).  23 
 24 
The ten-year survival for matched cementless and cemented UKR for low volume surgeons 25 
were 86.8% (CI=73.6-93.7) and 81.8% (CI=73.0-88.0), for medium were 94.3% (CI=92.2-26 
95.9) and 92.5% (CI=89.9-94.5) and for high were 97.5% (CI=96.5-98.2) and 94.2% 27 
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(CI=90.8-96.4). The revision rate for cementless was lower in all caseloads (HR 0.74, 0.79, 28 
0.80 respectively). 29 
 30 
Conclusions: Cementless fixation decreased the revision rate by about a quarter whatever the 31 
surgeon caseload. Caseload had a profound effect on survival: Low volume surgeons have a 32 
high revision rate with cemented or cementless fixation, so should consider stopping UKR 33 
or doing more. High volume surgeons using cementless UKR have a ten-year survival of 34 
97.5% which is similar to the best TKR.  35 



















INTRODUCTION  53 
 54 
The two main treatment options for end stage knee osteoarthritis which has failed to respond 55 
to conservative management are total knee replacement (TKR) and unicompartmental knee 56 
replacement (UKR). UKR offers substantial benefits over TKR1-3, but joint registries report 57 
higher revision rates 4-6.  58 
 59 
Surgeon caseload or volume is defined as the number of operations a surgeon performs per 60 
year and effects implant revision rates, with low volume surgeons having much higher 61 
revision rates than high volume surgeons7. This is particularly marked for UKR and is likely 62 
an important reason why UKR revision rates are so high.  In the UK the commonest 63 
surgeon caseload for UKR is 1 case/yr and the average is 5 cases/yr, compared to 34 cases/yr 64 
for TKR7.  65 
 66 
The Phase 3 Oxford (Zimmer Biomet, Swindon, United Kingdom) is the most commonly 67 
used partial knee system8. Leading revision indications include aseptic loosening and pain9, 68 
and therefore a cementless replacement was implanted. The only modifications are a porous 69 
titanium/hydroxyapatite coating and an extra femoral peg. Therefore, it is an ideal implant to 70 
compare fixation.   71 
 72 
Randomized studies have shown reduced radiolucent lines incidence with cementless UKR 73 
compared to cemented10. These studies were underpowered to compare revision rates. Large 74 
cementless Oxford UKR cohort studies report low revision rates11, 12, but are not different 75 
from similar large cemented studies13, 14. In contrast the New Zealand joint registry (NZJR) 76 
reports lower revision rates for the cementless Oxford6 UKR. Although the cementless does 77 
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appear to be a better implant15 another possible explanation for its improved results is that 78 
experienced high volume surgeons who obtained good results with UKR have predominantly 79 
changed to use  cementless components and low volume surgeons, who typically obtained 80 
worse results, have continued to use cemented components. There are concerns that 81 
cementless fixation is less forgiving than cemented with regard to obtaining stable 82 
fixation. Therefore low volume surgeons might actually get worse UKR results if they 83 
changed to cementless fixation.  It is not known whether the relative performance of 84 
cemented and cementless UKR is influenced by surgeon caseload.  85 
 86 
The National Joint Registry for England, Wales, Northern Ireland and Isle of Man (NJR) is 87 
the largest arthroplasty register4 but doesn’t report UKR results by fixation type. We analysed 88 
NJR data to determine the number of cemented and cementless UKR being used and to 89 
determine their survival. In addition, we used NJR data to assess the effect of surgeon 90 
caseload on the relative revision rate of cemented and cementless Oxford UKRs.   91 
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MATERIALS AND METHODS 92 
 93 
A retrospective observational study was performed using NJR records4. The NJR collects 94 
data on patient (including age, sex, body mass index), implant (including design, 95 
manufacturer, sizes) and surgical factors (including American Society of Anesthesiology 96 
grade16, approach, indication and surgeon grade) for each replacement procedure. The NJR 97 
has high levels of patient consent and link ability to subsequent surgery4.  98 
 99 
Anonymized patient data for all primary Oxford UKRs from January 1, 2005 to December 100 
31, 2016 (n=50,334) were obtained from the NJR database. After data cleaning, 40,522 101 
UKRs (30,814 cemented and 9,708 cementless) were eligible for inclusion (Figure 1).  102 
 103 
We undertook two analyses. Firstly with the cleaned unmatched data we determined the 104 
number of cemented and cementless UKR implanted each year and calculated the implant 105 
survival. This is the analysis the NJR would perform if they subdivided the Oxford UKR into 106 
cemented and cementless and ignores confounding factors. Secondly we matched the fixation 107 
groups to allow fair comparison. In both the matched and unmatched groups we explored the 108 
relationship between caseload and revision rate.  109 
 110 
The exposure of interest was surgeon caseload, defined as the mean number of UKRs 111 
performed per annum. Every surgeon in the NJR has a specific identifier which was used to 112 
calculate each operating surgeon’s UKR caseload for each calendar year. The mean caseload 113 
(cases per year) was then calculated for each surgeon, but excluding years in which surgeons 114 
were inactive to prevent artificial reductions for surgeons who started operating in later years 115 
or those who subsequently stopped performing UKRs7. Each patient was allocated a value 116 
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representing the caseload of the operating surgeon. Surgeon caseloads were grouped into low 117 
(<10 cases/yr), medium (10 to <30 cases/yr) and high volume (≥ 30 cases/yr).  These 118 
thresholds have previously been described by Liddle, et al7 and are evidence based unlike 119 
other thresholds17. Liddle, et al7 found, that revision rates fell steeply with increasing 120 
caseload up 10 cases/yr. Thereafter they decreased at a slower rate until they plateaued at ≥30 121 
cases/yr.  122 
 123 
Given the potential for other known patient18-21, surgical7, 22-26 and implant factors27, 28 to 124 
affect the revision rate we matched the cemented and cementless groups for multiple 125 
confounders using propensity scores. Logistic regression generated a propensity score 126 
representing the probability of receiving a cementless replacement. These scores were 127 
generated from patient, surgical and implant factors. The specific variables used for matching 128 
are summarized in Table 1, except body mass index (BMI) which had a large proportion of 129 
missing data, consistent with previous studies29, 30.  130 
 131 
We matched on the propensity score’s logit with a 0.02-SD calliper width with a one to one 132 
matching ratio. Greedy matching without replacement was utilised given its superior 133 
performance for estimating treatment effects31. A comparison of standardized mean 134 
differences (SMDs) before and after matching were used to assess for covariate imbalances 135 
between fixation groups. SMDs ≥10% are suggestive of covariate imbalance31. 14,814 UKRs 136 
(7,407 cemented and 7,407 cementless) were included in the matched analysis. 137 
 138 
Statistical analysis 139 
 140 
The study outcome of interest was implant survival. The endpoint for implant survival was all 141 
8 
 
cause revision surgery (any component inserted, exchanged or removed since primary 142 
surgery) for all indications. Cumulative implant survival was calculated using Kaplan-Meier 143 
analysis. Cumulative implant survival rates were compared between fixation groups across 144 
different caseload groups, using Cox regression models. To account for patient clustering 145 
within surgeons a multi-level frailty model was used. For clustering within the matched 146 
cohort a robust variance estimator was utilised. Adjusted models included covariates with 147 
residual imbalance after matching (defined as an SMD ≥10%). The revisions per 100 148 
component years are also reported with 95% confidence intervals (CIs) using the Clopper 149 
Pearson exact method32. All analyses were performed using Stata (Version 15.1; Lakeway 150 
Drive TX). 151 
 152 
SOURCE OF FUNDING 153 















RESULTS  167 
 168 
Unmatched analysis  169 
 170 
The unmatched cohort included 40,522 UKRs (30,814 cemented, 9,708 cementless UKRs). 171 
The number of cementless implanted each year has been increasing with 2832 cementless and 172 
1717 cemented implanted in 2016 (Table 1). The mean patient’s age at the time of 173 
implantation was 64.7 years (SD 9.5), with 21,747 males (53.7%). The mean BMI was 30.2 174 
kg/m2 (SD 5.0) and osteoarthritis was the surgical indication in 40,059 knees (98.9%).   175 
 176 
The mean follow up for cemented and cementless implants in the unmatched cohort were 6.4 177 
years (SD 3.1) and 3.5 years (SD 2.1), respectively. In total 2647 knees (258 cementless, 178 
2389 cemented) underwent revision surgery. 10-year implant survival rates for unmatched 179 
cementless and cemented UKRs were 93.3% (CI=89.8–95.7) and 89.1% (CI=88.6-89.6), 180 
respectively (Figure 2). Cementless UKRs had significantly better implant survival (hazard 181 
ratio (HR)=0.59, CI=0.52-0.68);p<0.001). However, the baseline characteristics for 182 
unmatched cemented and cementless implants differed significantly (Table 1).  The 183 
proportion of low volume surgeons was significantly (p<0.001) greater for cemented (43.7%) 184 
than cementless (27.4%), whereas the proportion of high volume surgeons was significantly 185 
greater (p<0.001) for cementless than cemented UKR (30.4% compared to 15.1%). 186 
 187 
Analysis of the effect of caseload on the whole unmatched cohort showed 10-year implant 188 
survival of 86.6% (CI=85.8-87.3), 90.8% (CI=90.1-91.5) and 94.1% (CI=93.2-94.8) in low, 189 
medium and high volume surgeons (Figure 3). The revision rates for medium and high 190 
volume surgeons were significantly lower than low volume surgeons. The HR’s were 0.67 191 
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(CI=0.62-0.73, p<0.001) and 0.42 (CI=0.37-0.48, p<0.001) respectively. The number of 192 
surgeons who were categorized as low, medium and high volume were 1275, 147 and 19, 193 
respectively. 194 
 195 
Matched analysis 196 
 197 
The matched cohort consisted of 14,814 UKRs (7407 cemented, 7407 cementless UKRs). 198 
The mean age was 64.7 years (SD 9.5), with 8659 males (58.4%). Mean BMI was 30.3 kg/m2 199 
(SD 5.0) and osteoarthritis was the surgical indication in 14,633 knees (98.8%).   200 
 201 
Patient, surgical and implant factors were balanced between fixation groups after propensity 202 
matching (Table 1). The only variable with residual imbalance was year of surgery, which did 203 
not alter the results when adjusted for in the regression models. The mean follow up for both 204 
cemented and cementless UKRs were 4 years (SD 2.0). Although BMI was not used in the 205 
matching process, it was adequately balanced both before and after matching (Table 1).  206 
 207 
In total 507 knees (218 cementless, 289 cemented) had revision surgery. Ten-year implant 208 
survival rates were 93.2% (CI=89.7-95.6) and 90.2% (CI=87.5-92.3) for cementless and 209 
cemented UKRs, respectively (Figure 4). Cementless UKRs had a significantly lower 210 
revision rate (HR=0.76, CI=0.64-0.91,p=0.002). 211 
 212 
In the matched cohort the 10-year implant survival for the cementless and cemented groups 213 
respectively for low volume surgeons were; 86.8% (CI=73.6-93.7) and 81.8% (CI=73.0–214 
88.0); for medium volume surgeons were 94.3% (CI=92.2-95.9) and 92.5 (CI=89.9-94.5); 215 
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and for high volume surgeons were 97.5% (CI=96.5-98.2) and 94.2% (CI=90.8-96.4). The 216 
10-year cumulative revision rates are presented in Figure 5.  217 
For all caseloads cementless UKRs had a lower revision rate than cemented UKRs. It was 218 
26% lower in low volume surgeons (HR=0.74,CI=0.56-0.98,p=0.03), 21% lower in medium 219 
volume surgeons (HR=0.79,CI=0.60–1.02,p=0.08) and 20% lower in high volume surgeons 220 
(HR=0.80,CI=0.52–1.24,p=0.32). There was no significant interaction between fixation and 221 
caseload (p=0.92). 222 
 223 
The revisions per 100 component years for the cementless and cemented groups respectively 224 
were; for low volume surgeons 1.12 (CI=0.89-1.37) and 1.49 (CI=1.24-1.78); for medium 225 
volume surgeons 0.73 (CI=0.59-0.89) and 0.93 (CI=0.77-1.11); and for high volume surgeons 226 
0.45 (CI=0.31-0.62) and 0.57 (CI=0.42-0.76). In the matched cohort the number of surgeons 227 

















DISCUSSION  243 
 244 
Our NJR data analysis shows the use of the cementless Oxford has been rapidly increasing, 245 
with twice as many cementless implanted as cemented in 2016. Despite the cementless 246 
Oxford UKR now being the most commonly used UKR the NJR has not published its results. 247 
In our unmatched analysis the 10-year survival of the cementless Oxford UKR was 93.3%, 248 
with the revision rate being 41% less than that of the cemented version. These results were 249 
virtually the same as those in the NZJR, which reports a 10 yr survival for the cementless of 250 
93%6. The cementless 10-year survival was better than or similar to that of all other UKRs 251 
reported in the NJR4. However, such comparisons are of little value as other surgeon or 252 
patient related factors are likely to have a greater influence on revision rate than the implant 253 
itself. Therefore, when making comparisons between implants it is important not only to 254 
match for confounding variables but also to consider their effects. 255 
 256 
Having matched for confounding variables the revision rate for the cementless was, as 257 
previously demonstrated, 24% less than the cemented15. Therefore, the remaining difference 258 
from 24% to 41% is likely explained by other variables such as caseload. We found that 259 
increasing caseload was associated with a marked decrease in revision rate and that more 260 
high volume surgeons and fewer low volume surgeons were using cementless implants rather 261 
than the cemented, confirming caseload is an influential variable. Importantly there was no 262 
interaction between caseload and fixation, with cementless fixation associated with a 263 
decreasing revision rate by about a quarter for low, medium and high volume surgeons. We 264 
believe this is the first time that a cementless knee replacement has been demonstrated to 265 
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have lower revision rates than its cemented counterpart for both experienced and 266 
inexperienced surgeons.  267 
Although cementless fixation is considered to be more durable in the long term than 268 
cemented, it is generally accepted that it is less forgiving33. In particular bone resections must 269 
be performed accurately, avoiding any gaps between the host bone and the components to 270 
ensure primary stability. It is therefore surprising that we found low volume UKR surgeons, 271 
who tend to be less experienced, have better results with cementless fixation than cemented. 272 
Furthermore, in the Oxford UKR, loads are mainly compressive with minimal shear, owing to 273 
ligament preservation and the mobile unconstrained bearing. This is advantageous for 274 
cementless fixation. Therefore, the results of this study may not apply to other types of UKR 275 
or TKR. 276 
 277 
We found with both cemented and cementless UKRs the revision rate decreased with 278 
increasing surgeon volume. Although this probably relates to surgical technique it may also 279 
relate to the indications for UKR.  The primary indications are anteromedial osteoarthritis 280 
with bone-on-bone arthritis medially, full thickness cartilage present laterally, and 281 
functionally normal ligaments34. These criteria are assessed radiographically and confirmed 282 
intraoperatively34 but are not collected by the NJR which only reports the primary indication 283 
for surgery. Therefore from NJR data it is not possible to determine the precise indications 284 
for surgery. However studies suggest the indications are satisfied in up to 50% of knee 285 
replacements35. An insight into the indications can be determined from the usage of UKR, 286 
which is defined as the proportion of primary knee replacements that are UKR compared to 287 
TKR. Previous work has shown that surgeons with high usage (≥30%) tend to use the correct 288 
indications and achieve better results, whereas surgeons with low usage (<10%) often use 289 




Low volume UKR surgeons, had high 10-year revision rates whether they used cementless or 292 
cemented UKR. We believe that these surgeons should considering focus on their UKR 293 
practice rather than the type of implant fixation. Given they had high revision rates they 294 
should consider either stopping doing UKR or see if, by adhering to the recommended 295 
indications, they might increase their caseload to more than 10 cases/year3, 35, 37. From 80% to 296 
90% of surgeons who have implanted UKR were considered low volume. However the 297 
majority of these surgeons had a large enough knee replacement practice to likely be able to 298 
do more than 10 UKR per year if they adhered to the recommended indications7, 35. 299 
Therefore, potentially many more UKR could be implanted which hopefully would lead to 300 
improvement in the overall results. Medium and high volume UKR surgeons using cemented 301 
components should consider changing to cementless fixaton as it may improve their 302 
outcomes. High volume surgeons using cementless components were found to achieve very 303 
good results with a 10-year implant survival of 97.5% which is similar as that achieved by the 304 
best TKR4.   305 
 306 
The main limitation is that our work is based on Registry data, which reports revision and not 307 
other outcomes. Registries can underreport revisions although this should not differ between 308 
groups38, 39.  Furthermore, propensity matching has limitations of potential residual 309 
confounding and can reduce the result’s generalizability. Fixation groups were not perfectly 310 
matched on the year of surgery, given cementless components were introduced after 311 
cemented. Although surgical practices typically improve with time, our results did not change 312 
when we adjusted year of surgery in the regression models. A substantial proportion of 313 
patients had missing BMI data, preventing us from matching on this variable. However, BMI 314 
was balanced between groups both before and after propensity matching. The only way to 315 
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achieve perfect matching is with a randomized trial. However, to compare revision rates 316 
across different surgeon caseloads would be virtually impossible as it would require a very 317 
large sample size and many surgeons with a range of different caseloads. Therefore 318 
propensity matching is the best way of performing this study. 319 
 320 
In conclusion, surgeon caseload had a profound effect on implant survival in both cemented 321 
and cementless knee UKRs with low caseload being associated with higher revision rates for 322 
both implant types. Surgeon caseload, however did not affect the relative performance of 323 
cemented and cementless replacements; the revision rate of the cementless replacements were 324 
about a quarter less than cemented across low, medium and high surgeon caseloads 325 
suggesting superior implant performance. Low volume UKR surgeons had high revision rates 326 
and we suggest that they should consider either stopping or doing more UKR. Medium and 327 
high volume surgeons, using cemented Oxford UKR components should consider changing 328 
to cementless fixation. High volume surgeons using cementless UKR achieved particularly 329 
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Table 1. Patient, implant and surgical factors before and after matching. Abbreviations: 
SD (Standard deviation), SMD (Standardised mean difference), VTE (Venous 
thromboembolism). 
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Cementless UKRs had a significantly reduced revision rate compared with cemented UKRs 
(HR=0.76,CI 0.64-0.91,p=0.002). 
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For all caseloads cementless UKRs had a lower revision rate than cemented UKRs. It was 26% 
reduced in low volume surgeons, 21% reduced in medium volume surgeons and 20% reduced in 
high volume surgeons. 
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